Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan Weekly vs Day 1-5 in Platinum-Resistant Ovarian Cancer
NCT00170677Phase 2Completed
- Sponsor
- NOGGO
- Start
- Sep 2005
- Primary completion
- Jan 2013
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan liposome in ovarian cancer, sponsored by NOGGO. Started Sep 2005; status: completed.
02
Drugs
topotecan liposome
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00170677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170677.